Combined with the above results, LNX2, BIRC6, ANKRD46, TGFB1, PSEN1, and ALDH2 have the potential to be diagnostic biomarkers for MCI and diabetes, although they need to be further validated. This evidence concerns the gene ALDH2 and diabetes mellitus.